Madrona Venture Group, LLC

CIK: 0001887785Latest portfolio: $22.1M · Q4 2025

Holdings

3

Total Value

$22.1M

New Positions

3

Closed Positions

0

Top Holdings

#StockSharesValue% PortfolioChangeType
1
NAUTNAUTILUS BIOTECHNOLOGY INC
6,020,770$11.7M53.24%NEW
2
PATHUIPATH INC
607,673$10.0M45.16%NEW
3
DNAGINKGO BIOWORKS HOLDINGS, INC.
42,430$353K1.60%NEW

Quarterly Changes

New Positions

Closed Positions

No closed positions this quarter

Sector Breakdown

Healthcare0.0% ($11.7B)
Technology0.0% ($10.0M)

Filing History

QuarterFiling DatePortfolio ValueHoldings
Q4 2025Feb 13, 2026$22.1M3
Q3 2025Oct 31, 2025$13.8M0
Q2 2025Aug 11, 2025$12.6M3
Q1 2025May 7, 2025$28.5M3
Q4 2024Feb 14, 2025$53.8M4

Fund Information

CIK0001887785
Most Recent FilingFeb 13, 2026
Number of Filings5

Madrona Venture Group, LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $22.1M across 3 holdings. The largest position is NAUTILUS BIOTECHNOLOGY INC (NAUT), representing 53.2% of the portfolio. Compared to the previous quarter, the fund opened 3 new positions and closed 0 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.